Nuzenio

Exagen Sold Us

Exagen Sold Us news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 11:50:32 GMTExagen Inc. (NASDAQ:XGN) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
Wed, 05 Aug 2026 13:34:09 GMTInsiders At Exagen Sold US$680k Of Stock Potentially Indicating Weakness - Moomoo
Wed, 05 Aug 2026 00:16:56 GMTExagen (XGN) Stock Jumps On Record Revenue But Profit Timing Remains Unclear - simplywall.st
Tue, 04 Aug 2026 23:20:11 GMTExagen Inc. Stock 12‑Month Price Target Raised to $8.71, Implies 86% Upside - TradingView
Tue, 04 Aug 2026 12:20:05 GMTExagen Reports Record Second-Quarter Revenue and Narrows Losses, Raises Full-Year 2026 Guidance - Moomoo
Wed, 29 Jul 2026 07:00:00 GMTEarnings Preview: Exagen to Report Financial Results Pre-market on August 04 - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Exagen Sold Us.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.